Marc Balmer

Dr. Marc Balmer

University of Zurich, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2020 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
MBMarc Balmer
Marc Balmer
Benedikt SpiesBenedikt Spies
Benedikt Spies
Ralf KohalRalf Kohal
Ralf Kohal
CHChristoph Hans‐Franz Hämmerle
Christoph Hans‐Franz Hämmerle
KVKirstin Vach
Kirstin Vach
RJRonald E. Jung
Ronald E. Jung

10 August 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Ralf KohalRalf Kohal
Ralf Kohal
Benedikt SpiesBenedikt Spies
Benedikt Spies
Kirstin VachKirstin Vach
Kirstin Vach
MBMarc Balmer
Marc Balmer
SPStefano Pieralli
Stefano Pieralli
Mid-term data on zirconia oral implants is very rare. Therefore, the aim of this prospective clinical investigation was to evaluate the survival rate and the marginal bone loss of a one-piece zirconia implant after five years. Patient-reported outcomes were also recorded. Zirconia implants to support single crowns (SC) or a 3-unit fixed dental prosthesis (FDP) were placed and subsequently restored. After the insertion of the implants, at prosthetic delivery, and after five years, standardized radiographs were taken to evaluate marginal bone loss (MBL). For bone tissue evaluation, linear mixed models with random intercepts were fitted. Twenty-seven patients received one implant for an SC and 13 patients received two implants for a 3-unit FDP. Three patients each lost one implant for an SC before prosthetic delivery. Thirty-five patients were seen after five years, and no further implant was lost. The cumulative five-year implant survival rate was 94.3%. The MBL from implant installation up to five years was 0.81 mm. The MBL from implant installation to prosthetic delivery was statistically significant (p < 0.001). Patients perceived a significant improvement in function, esthetics, sense, speech, and self-esteem from pretreatment up to the five-year follow-up. The present findings substantiate the clinical applicability of this implant system.

19 October 2021 in Clinical Oral Implants Research
Verified
Journal Article
Open access
PDF file
FSFrank A. Spitznagel
Frank A. Spitznagel
MBMarc Balmer
Marc Balmer
DWDaniel B Wiedemeier
Daniel B Wiedemeier
RJRonald E. Jung
Ronald E. Jung
PGPetra Christine Gierthmuehlen
Petra Christine Gierthmuehlen
Objective: To analyze the clinical outcomes of all‐ceramic single crowns (SCs) and fixed dental prostheses (FDPs) supported by ceramic implants.Materials and Methods: Based on a focused question and customized PICO framework, electronic (Medline/EMBASE/Cochrane) and manual searches for studies reporting the clinical outcomes of all‐ceramic SCs and FDPs supported by ceramic implants ≥12 months were performed. The primary outcomes were reconstruction survival and the chipping proportion. The secondary outcomes were implant survival, technical complications, and patient‐related outcome measurements. Meta‐analyses were performed after 1, 2, and 5 years using random‐effect meta‐analyses.Results: Eight of the 1,403 initially screened titles and 55 full texts were included. Five reported on monolithic lithium disilicate (LS2) SCs, one on veneered zirconia SCs, and two on veneered zirconia SCs and FDPs, which reported all on cement‐retained reconstructions (mean observation: 12.0–61.0 months). Meta‐analyses estimated a 5‐year survival rate of 94% (95% confidence interval [CI]: 82%–100%) for overall implant survival. Reconstruction survival proportions after 5 years were: monolithic LS2, 100% (95%CI: 95%–100%); veneered zirconia SCs, 89% (95%CI: 62%–100%); and veneered zirconia FDPs 94% (95%CI: 81%–100%). The chipping proportion after 5 years was: monolithic LS2, 2% (95%CI: 0%–11%); veneered zirconia SCs, 38% (95%CI: 24%–54%); and veneered zirconia FDPs, 57% (95%CI: 38%–76%). Further outcomes were summarized descriptively.Conclusions: Due to the limited data available, only tendencies could be identified. All‐ceramic reconstructions supported by ceramic implants demonstrated promising survival rates after mid‐term observation. However, high chipping proportions of veneered zirconia SCs and, particularly, FDPs diminished the overall outcome. Monolithic LS2 demonstrated fewer clinical complications. Monolithic reconstructions could be a valid treatment option for ceramic implants.

12 January 2018 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
MBMarc Balmer
Marc Balmer
Benedikt SpiesBenedikt Spies
Benedikt Spies
KVKirstin Vach
Kirstin Vach
Ralf KohalRalf Kohal
Ralf Kohal
CHChristoph H. F. Hämmerle
Christoph H. F. Hämmerle
RJRonald E. Jung
Ronald E. Jung

22 December 2023 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
Tim JodaTim Joda
Tim Joda
MBMarc Balmer
Marc Balmer
RJRonald E. Jung
Ronald E. Jung
AIAlexis Ioannidis
Alexis Ioannidis

10 April 2019 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
Benedikt SpiesBenedikt Spies
Benedikt Spies
MBMarc Balmer
Marc Balmer
RJRonald E. Jung
Ronald E. Jung
ISIrena Sailer
Irena Sailer
Kirstin VachKirstin Vach
Kirstin Vach
Ralf KohalRalf Kohal
Ralf Kohal